Article Figures & Data
Tables
- Table 1.
GFR, peritoneal creatinine clearance, and fluid removal at volumes baseline and at 6, 12, 18, and 24 months of follow-upa
Parameter Baseline 6 Mo 12 Mo 18 Mo 24 Mo aCcrp, peritoneal creatinine clearance; UF, ultrafiltration. GFR and Ccrp are normalized to 1.73 m2. n 601 469 290 147 69 GFR (L/wk) 37.7 28.7 21.4 19.4 14.8 Ccrp (L/wk) 44.3 45.8 46.4 45.3 47.2 Urine volume (ml/24 h) 670 519 428 379 335 Net peritoneal UF (ml/24 h) 958 1478 1807 1677 1951 Total fluid removal (ml/24 h) 1628 1997 2235 2056 2286 - Table 2.
Cox model of relative risk of death with time-dependent Ccr divided into peritoneal clearance and GFR and entered as time-dependent covariatesa
Variable Relative Risk 95% Confidence Limit aCVD, cardiovascular disease; LA, low average; HA, high average; H, high; SGA, subjective global assessment. Age 1.02 1.005-1.044 CVD 2.42 1.499-3.904 Diabetes mellitus 1.25 0.769-2.036 Serum albumin 0.96 0.912-1.000 LA transport 1.66 0.379-7.218 HA transport 2.33 0.554-9.801 H transport 2.01 0.430-9.357 SGA 0.74 0.647-0.842 Ccrp (5 L/wk per 1.73 m2 greater) 1.00 0.898-1.105 GFR (5 L/wk per 1.73 m2 greater) 0.88 0.829-0.943 - Table 3.
Cox model of relative risk for death with urine volume forced in as a time-dependent covariate
Variable Relative Risk 95% Confidence Limits Age (1 yr older) 1.02 1.002-1.041 CVD 2.37 1.465-3.821 Diabetes mellitus 1.31 0.807-2.134 Serum albumin (1 g/L increase) 0.96 0.914-1.003 LA transport 1.84 0.418-8.075 HA transport 2.71 0.631-11.623 H transport 2.46 0.523-11.590 SGA (1 unit greater) 0.78 0.672-0.876 Ccrp (5 L/wk per 1.73 m2 greater) 0.93 0.795-1.079 GFR (5 L/wk per 1.73 m2 greater) 0.99 0.943-1.044 Urine volume (250 ml daily greater) 0.64 0.508-0.800
Relative Contribution of Residual Renal Function and Peritoneal Clearance to Adequacy of Dialysis: A Reanalysis of the CANUSA Study
Jump to section
More in this TOC Section
Cited By...
- Contrast media in patients with kidney disease: An update
- Association of Tubular Solute Clearance with Symptom Burden in Incident Peritoneal Dialysis
- Removal of Protein-Bound Uremic Toxins by Liposome-Supported Peritoneal Dialysis
- Higher eGFR at Dialysis Initiation Is Not Associated with a Survival Benefit in Children
- Can Lower Dialysate Sodium Concentrations Contribute to Blood Pressure Control in Peritoneal Dialysis?
- Computer Simulations of Continuous Flow Peritoneal Dialysis Using the 3-Pore Model--A First Experience
- Assessment and Management of Hypertension among Patients on Peritoneal Dialysis
- Association of Continuation of Loop Diuretics at Hemodialysis Initiation with Clinical Outcomes
- Early Peritoneal Dialysis Technique Failure: Review
- Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis
- Current Uses of Dietary Therapy for Patients with Far-Advanced CKD
- Rapid Change in Residual Renal Function Decline Is Associated with Lower Survival and Worse Residual Renal Function Preservation in Peritoneal Dialysis Patients
- The Use of a Multidimensional Measure of Dialysis Adequacy--Moving beyond Small Solute Kinetics
- Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: The balANZ Trial
- Prognostic Value of Residual Urine Volume, GFR by 24-hour Urine Collection, and eGFR in Patients Receiving Dialysis
- Preservation of Residual Kidney Function and Urine Volume in Patients on Dialysis
- Kinetic Modeling of Incremental Ambulatory Peritoneal Dialysis Exchanges
- Association of Alternative Approaches to Normalizing Peritoneal Dialysis Clearance with Mortality and Technique Failure: A Retrospective Analysis Using the United States Renal Data System-Dialysis Morbidity and Mortality Study, Wave 2
- Preserving Residual Kidney Function in Hemodialysis Patients--Back in the Spotlight
- Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients
- Risk Factors for Decline of Residual Renal Function in Children Treated With Peritoneal Dialysis
- The Current State of Peritoneal Dialysis
- Does Changing the Volume Matter? The Relationship of Urine Volume and Dialysis Intensity
- Hydration Status of Patients Dialyzed with Biocompatible Peritoneal Dialysis Fluids
- Is the Effect of Low-GDP Solutions on Residual Renal Function Mediated by Fluid State? An Enigmatic Question which Still Needs to be Solved
- Evaluating Hyponatremia in Non-Diabetic Uremic Patients on Peritoneal Dialysis
- A Patient on Peritoneal Dialysis with Refractory Volume Overload
- Serum Cystatin C Does Not Predict Mortality or Treatment Failure in Peritoneal Dialysis: A Prospective Study
- Pharmacokinetic and Dynamic of Furosemide in Peritoneal Dialysis Patients
- The Impact of Timing of Dialysis Initiation on Mortality in Patients with Peritoneal Dialysis
- Predicting Risk in Peritoneal Dialysis: Is Membrane Biology Destiny?
- A Pilot Study Examining the Effects of Tolvaptan on Residual Renal Function in Peritoneal Dialysis for Diabetics
- Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis
- Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis
- The Impact of Transfer from Hemodialysis on Peritoneal Dialysis Technique Survival
- Risk Factors for Mortality in Chinese Patients on Continuous Ambulatory Peritoneal Dialysis
- Comparison of the Impact of "Fast Decline" in Residual Renal Function and "Initial Anuria" on Long-Term Outcomes in CAPD Patients
- Utility of Urinary Biomarkers in Predicting Loss of Residual Renal Function: The balANZ Trial
- Effect of Biocompatible Peritoneal Dialysis Solution on Residual Renal Function: A Systematic Review of Randomized Controlled Trials
- Serum Concentrations of p-Cresyl Sulfate and Indoxyl Sulfate, but Not Inflammatory Markers, Increase in Incident Peritoneal Dialysis Patients in Parallel with Loss of Residual Renal Function
- Clinical Experience Using Bioimpedance to Optimize Blood Pressure Control
- Dialysis Modality and Correction of Uremic Metabolic Acidosis: Relationship with All-Cause and Cause-Specific Mortality
- Association of Modality with Mortality among Canadian Aboriginals
- Effect of Timing of Dialysis Commencement on Clinical Outcomes of Patients with Planned Initiation of Peritoneal Dialysis in the Ideal Trial
- Serum {beta}-Trace Protein and Risk of Mortality in Incident Hemodialysis Patients
- Serum Potassium and Cause-Specific Mortality in a Large Peritoneal Dialysis Cohort
- Effluent Free Radicals are Associated with Residual Renal Function and Predict Technique Failure in Peritoneal Dialysis Patients
- Effects of Biocompatible versus Standard Fluid on Peritoneal Dialysis Outcomes
- Residual Renal Function Calculated from Serum Cystatin C Measurements and Knowledge of the Weekly Standard Kt/V Urea
- The Effect of Racial Origin on Total Body Water Volume in Peritoneal Dialysis Patients
- N-Acetylcysteine Improves Residual Renal Function in Peritoneal Dialysis Patients: A Pilot Study
- Selection Bias Explains Apparent Differential Mortality between Dialysis Modalities
- Early Start of Dialysis: A Critical Review
- Benfotiamine Protects against Peritoneal and Kidney Damage in Peritoneal Dialysis
- Assessing Creatinine Clearance from Modification of Diet in Renal Disease Study Equations in the ADEMEX Cohort: Limitations and Potential Applications
- Volume Status in Peritoneal Dialysis
- CLINICAL PRACTICE GUIDELINES AND RECOMMENDATIONS ON PERITONEAL DIALYSIS ADEQUACY 2011
- Contribution of Residual Function to Removal of Protein-Bound Solutes in Hemodialysis
- Role of Residual Renal Function in Phosphate Control and Anemia Management in Chronic Hemodialysis Patients
- TREATMENT WITH ANGIOTENSIN II INHIBITORS AND RESIDUAL RENAL FUNCTION IN PERITONEAL DIALYSIS PATIENTS
- CYSTATIN C MEASUREMENTS IN THE ASSESSMENT OF RESIDUAL RENAL FUNCTION, DIALYSIS ADEQUACY, AND BEYOND
- Residual Renal Function in Peritoneal Dialysis After Renal Transplant Failure
- Strategies for Improving Long-Term Survival in Peritoneal Dialysis Patients
- ON SMALL SOLUTE CLEARANCE AND PATIENT OUTCOMES: EVIDENTIAL PRACTICE OR OBSERVATIONAL TREPIDATION?
- PERITONEAL SMALL SOLUTE CLEARANCE IS NONLINEARLY RELATED TO PATIENT SURVIVAL IN THE AUSTRALIAN AND NEW ZEALAND PERITONEAL DIALYSIS PATIENT POPULATIONS
- ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PERITONEAL DIALYSIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
- Comparison of Volume Overload with Cycler-Assisted versus Continuous Ambulatory Peritoneal Dialysis
- PREVIOUS COMORBIDITY AND LACK OF PATIENT FREE CHOICE OF TECHNIQUE PREDICT EARLY MORTALITY IN PERITONEAL DIALYSIS
- PERITONEAL DIALYSIS AND PRESERVATION OF RESIDUAL RENAL FUNCTION
- Advances and innovations in dialysis in the 21st century
- Predictive Value of Brain Natriuretic Peptides in Patients on Peritoneal Dialysis: Results from the ADEMEX Trial
- Is the Declining Use of Long-Term Peritoneal Dialysis Justified by Outcome Data?
- Administration of Tobramycin in the Beginning of the Hemodialysis Session: A Novel Intradialytic Dosing Regimen
- 30 YEARS OF PERITONEAL DIALYSIS DEVELOPMENT: THE PAST AND THE FUTURE
- THERAPEUTIC OPTIONS FOR PRESERVATION OF RESIDUAL RENAL FUNCTION IN PATIENTS ON PERITONEAL DIALYSIS
- THE "HEART" OF PERITONEAL DIALYSIS
- CLINICAL EFFECTS OF COMBINED THERAPY WITH PERITONEAL DIALYSIS AND HEMODIALYSIS
- CARDIOVASCULAR RISK FACTORS IN PERITONEAL DIALYSIS PATIENTS REVISITED